Clinical Trials Browser

HER2-positive Breast Cancer × Drug Therapy × Clear all

NCT04481932 2020-07-22

Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer

Phase 2 Recruiting

HER2-positive Breast Cancer